In the ROC analysis between control and IPMN, the AUC and diagnostic accuaracy of ExmiRs were superior to those of CA19–9 and CEA (Fig. 3b). The gene discussed is CEACAM5; the disease is pancreatic intraductal papillary-mucinous neoplasm.